ZIMV * Stock Overview
Develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
ZimVie Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$230.00 |
| 52 Week High | US$233.00 |
| 52 Week Low | US$230.00 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -52.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZIMV * | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how ZIMV * performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how ZIMV * performed against the MX Market.
Price Volatility
| ZIMV * volatility | |
|---|---|
| ZIMV * Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: ZIMV * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ZIMV *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 2,700 | Vafa Jamali | www.zimvie.com |
ZimVie Inc., a medical technology company, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; hardware and software solutions consist of intraoral scanners and RealGUIDE; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether.
ZimVie Inc. Fundamentals Summary
| ZIMV * fundamental statistics | |
|---|---|
| Market cap | Mex$3.37b |
| Earnings (TTM) | -Mex$1.50b |
| Revenue (TTM) | Mex$16.19b |
0.2x
P/S Ratio-2.2x
P/E RatioIs ZIMV * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZIMV * income statement (TTM) | |
|---|---|
| Revenue | US$894.02m |
| Cost of Revenue | US$279.45m |
| Gross Profit | US$614.57m |
| Other Expenses | US$697.42m |
| Earnings | -US$82.85m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 01, 2023
| Earnings per share (EPS) | -3.12 |
| Gross Margin | 68.74% |
| Net Profit Margin | -9.27% |
| Debt/Equity Ratio | 71.8% |
How did ZIMV * perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/28 08:52 |
| End of Day Share Price | 2023/07/31 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ZimVie Inc. is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matt Miksic | Barclays |
| Matthew Miksic | Credit Suisse |
| null null | Equisights |